How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy?

od Hasegawa, Takahiro, Uno, Hajime, Wei, Lee-Jen
Izdano u J Clin Oncol (2016)

Estimating and Interpreting the Overall Survival Benefit of Checkpoint Inhibitors via Meta-analysis

od Uno, Hajime, Tian, Lu, Wei, Lee-Jen
Izdano u JAMA Oncol (2018)

Meta-analysis to Evaluate High-Dose Therapy Followed by Stem Cell Transplant in Patients With Multiple Myeloma

od Claggett, Brian, Tian, Lu, Wei, Lee-Jen
Izdano u JAMA Oncol (2018)

Demonstrating Noninferiority of Accelerated Radiotherapy With Panitumumab vs Standard Radiotherapy With Cisplatin in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma

od Cheng, David, Pak, Kyongsun, Wei, Lee-Jen
Izdano u JAMA Oncol (2017)

Restricted Mean Survival Time in Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure

od Shi, Sandra, Wei, Lee-Jen, Kim, Dae
Izdano u Innov Aging (2020)

Restricted Mean Survival Time as a Measure to Interpret Clinical Trial Results

od Kim, Dae Hyun, Uno, Hajime, Wei, Lee-Jen
Izdano u JAMA Cardiol (2017)

On the covariate-adjusted estimation for an overall treatment difference with data from a randomized comparative clinical trial

od Tian, Lu, Cai, Tianxi, Zhao, Lihui, Wei, Lee-Jen
Izdano 2012

Treatment selections using risk–benefit profiles based on data from comparative randomized clinical trials with multiple endpoints

od Claggett, Brian, Tian, Lu, Castagno, Davide, Wei, Lee-Jen
Izdano u Biostatistics (2015)

Quantifying the totality of treatment effect with multiple event-time observations in the presence of a terminal event from a comparative clinical study

od Claggett, Brian, Tian, Lu, Fu, Haoda, Solomon, Scott D., Wei, Lee-Jen
Izdano u Stat Med (2018)

Comment on “Interpreting Clinical Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer (BRPC)”...

od McCaw, Zachary R., Tian, Lu, Kim, Dae Hyun, Wei, Lee-Jen
Izdano u Ann Surg (2019)

Utility of Restricted Mean Survival Time for Analyzing Time to Nursing Home Placement Among Patients With Dementia

od Kim, Dae Hyun, Li, Xihao, Bian, Shijia, Wei, Lee-Jen, Sun, Ryan
Izdano u JAMA Netw Open (2021)

Sex as a predictor of response to cancer immunotherapy

od Claggett, Brian, Tian, Lu, McCaw, Zachary R, Takeuchi, Masahiro, Wei, Lee-Jen
Izdano u Lancet Oncol (2018)

Evaluating Treatment Effect Based on Duration of Response for a Comparative Oncology Study

od Huang, Bo, Tian, Lu, Talukder, Enayet, Rothenberg, Mace, Kim, Dae Hyun, Wei, Lee-Jen
Izdano u JAMA Oncol (2018)

Trifluridine/tipiracil in metastatic gastric cancer

od McCaw, Zachary R, Kim, Dae Hyun, Tian, Lu, Fu, Haoda, Wei, Lee-Jen
Izdano u Lancet Oncol (2019)

Impact of Acute Serum Creatinine Elevation in Patients Treated with Nesiritide

od Elkayam, Uri, Janmohamed, Munir, Hatamizadeh, Parta, Heywood, J. Thomas, Wei, Lee‐Jen, Mills, Roger M.
Izdano u Clin Cardiol (2009)

Survival Analysis of Treatment Efficacy in Comparative Coronavirus Disease 2019 Studies

od McCaw, Zachary R, Tian, Lu, Kim, Dae Hyun, Localio, A Russell, Wei, Lee-Jen
Izdano u Clin Infect Dis (2020)

Estimating Treatment Effect With Clinical Interpretation From a Comparative Clinical Trial With an End Point Subject to Competing Risks

od Zhao, Lihui, Tian, Lu, Claggett, Brian, Pfeffer, Marc, Kim, Dae Hyun, Solomon, Scott, Wei, Lee-Jen
Izdano u JAMA Cardiol (2018)

Pravastatin for Primary Prevention in Older Adults: Restricted Mean Survival Time Analysis

od Orkaby, Ariela R., Rich, Michael W., Sun, Ryan, Lux, Eliah, Wei, Lee-Jen, Kim, Dae Hyun
Izdano u J Am Geriatr Soc (2018)

Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes

od Uno, Hajime, Schrag, Deborah, Kim, Dae Hyun, Tang, Dejun, Tian, Lu, Rugo, Hope S, Wei, Lee-Jen
Izdano u JNCI Cancer Spectr (2019)

Quantification of Long-term Survival Benefit in a Comparative Oncology Clinical Study

od Horiguchi, Miki, Tian, Lu, Uno, Hajime, Cheng, SuChun, Kim, Dae Hyun, Schrag, Deb, Wei, Lee-Jen
Izdano u JAMA Oncol (2018)